After the CDC issued its 2016 Opioid Prescribing Guideline, which focused on recommendations for primary care physicians, many physicians greatly limited prescribing opioids. This was in response to the opioid epidemic in our country which had an impact on reducing opioid abuse. However, it also may have left patients undertreated for pain given the 2016 guideline’s emphasis on not prescribing opioids. In November 2022, the CDC issued updated guidance for a broader group of clinicians. This blog series provides an overview of the more-than-60-page CDC guidance. This first blog will provide an overview of what the guidance is intended to accomplish and how it is presented. Our attorneys are experienced in advising healthcare businesses and pain management practices. If you have pain management prescribing questions or would like to discuss this blog post, you may contact our healthcare and business law firm at (404) 685-1662 (Atlanta) or (706) 722-7886 (Augusta), or by email, info@littlehealthlaw.com. You may also learn more about our law firm by visiting www.littlehealthlaw.com.
First, the updated guidance “is intended for clinicians who are treating outpatients aged ≥18 years with acute (duration of <1 month), subacute (duration of 1–3 months), or chronic (duration of >3 months) pain, and excludes pain management related to sickle cell disease, cancer-related pain treatment, palliative care, and end-of-life care.” Continue reading ›
Little Health Law Blog


Our healthcare and business law firm previously published a blog post on the
Given the increased use of telehealth during the Public Health Emergency (“PHE”), the Centers for Medicare and Medicaid Services (CMS) passed a final rule modifying the rules around when Medicare will reimburse for mental health visits. A previous blog post analyzed Federal laws and rules governing telehealth visits, including the general
In our previous post reviewing the Georgia Composite Medical Board’s (“Medical Board” or “GCMB”)
Welcome to the first installment of our business and healthcare law firm’s monthly medical board meeting review, focusing on the Georgia Composite Medical Board (“GCMB” or “Medical Board”). As a healthcare law firm with many physician clients, it is our duty to stay up to date with the Medical Board’s positions and changes so as to better inform our clients. We hope that by providing a review of the Medical Board’s monthly meeting minutes, our readers and provider clients will be able to better navigate the Medical Board successfully. If you have 
More than 2,000 opioid lawsuits are pending nationwide. A large portion of these lawsuits target drug manufacturing companies for their contributions to the opioid epidemic that is plaguing the country.
This month, the abrupt closing of four Tennessee
The exposure and concern surrounding the opioid epidemic is at an all time high. Notwithstanding the urgency of the issue itself, this publicity places increased pressure on the intervening parties—sub-agencies of the